Tel +49 (0)30 560 42240, Mon - Fri, 9am - 1pm

Pilot study on the telomerase activator TA-65® for early age-related macular degeneration.

Telomere shortening and corresponding cellular senescence of the retinal pigment epithelium contribute to the changes in age-related macular degeneration.
The activation of the enzyme telomerase can add telomeric DNA to retinal pigment epithelium chromosome ends and has been proposed for the treatment of age-related macular degeneration.
This study, which focuses on macular degeneration, is a model for the treatment of age-related diseases with TA-65®.
Coad Thomas Dow, Calvin B Harley January 28, 2016
1McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA; 2Chippewa Valley Eye Clinic, Eau Claire, Wisconsin, WI, USA; 3Independent Telomere Biology Consultant, Murphys, CA, USA

Read here (PDF)

Please enter these characters in the following text field.

The fields marked with * are required.